Health● Low28m ago · Nov 9, 2026, 2:30 PM
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
GlobeAlert Desk · curated from CNBC · North America
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Health
Not flagged as developing.
North America theater · last 7 days
rising · 31 in the last 24h585
events logged
94
risk index / 100
Attacks & Assaults 204Robberies & Theft 162Shootings 114Rocket Launches 40Kidnappings 19
- Cyber activity (95 reports)Cyber Threats · · 11m ago
- Protest activity (109 reports)Protests · · 12m ago
- Conflict activity (122 reports)Conflict Events · · 12m ago
More in Health
Health1h agoCould supplements be the next big opportunity in the GLP-1 weight-loss drug boom?CNBCHealth1h agoEdo Govt Warns Against Medical Quackery After Newborn Left In Critical ConditionChannels TVHealth1h agoMusiala’s condition cannot be cured, may never return to best — Bayern presidentVanguard NigeriaHealth1h agoThese states are offering extra ACA premium subsidies in 2027CNBC